These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 15657659)
1. Prognostic implications of hMLH1 and p53 immunohistochemical status in right-sided colon cancer. Smyth EF; Sharma A; Sivarajasingham N; Hartley J; Monson JR; Cawkwell L Dis Colon Rectum; 2004 Dec; 47(12):2086-91; discussion 2091-2. PubMed ID: 15657659 [TBL] [Abstract][Full Text] [Related]
2. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer. Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399 [TBL] [Abstract][Full Text] [Related]
3. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas. Wright CL; Stewart ID Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer. Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659 [TBL] [Abstract][Full Text] [Related]
5. Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer. Park IJ; Kim HC; Kim JS; Yu ES; Yu CS; Kim JC Hepatogastroenterology; 2005; 52(62):450-4. PubMed ID: 15816455 [TBL] [Abstract][Full Text] [Related]
6. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Wang L; Cunningham JM; Winters JL; Guenther JC; French AJ; Boardman LA; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN Cancer Res; 2003 Sep; 63(17):5209-12. PubMed ID: 14500346 [TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and p53 mutations in sporadic right and left colon carcinoma: different clinical and molecular implications. Lleonart ME; García-Foncillas J; Sánchez-Prieto R; Martín P; Moreno A; Salas C; Ramón y Cajal S Cancer; 1998 Sep; 83(5):889-95. PubMed ID: 9731891 [TBL] [Abstract][Full Text] [Related]
9. Mononucleotide markers of microsatellite instability in carcinomas of the urinary bladder. Saetta AA; Goudopoulou A; Korkolopoulou P; Voutsinas G; Thomas-Tsagli E; Michalopoulos NV; Patsouris E Eur J Surg Oncol; 2004 Sep; 30(7):796-803. PubMed ID: 15296997 [TBL] [Abstract][Full Text] [Related]
10. Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients. Taubert HW; Bartel F; Kappler M; Schuster K; Meye A; Lautenschläger C; Thamm-Mücke B; Bache M; Schmidt H; Holzhausen HJ; Würl P Cancer; 2003 May; 97(9):2273-8. PubMed ID: 12712483 [TBL] [Abstract][Full Text] [Related]
11. [Effect of eukaryotic expression plasmid DNA methyltransferase gene on methylation status and transcription level of DNA mismatch repair genes in human colon cancer cell line]. Lu R; Fang JY; Zhu HY; Chen YX; Cheng ZH; Li EL Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1014-7. PubMed ID: 15312538 [TBL] [Abstract][Full Text] [Related]
12. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022 [TBL] [Abstract][Full Text] [Related]
13. Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Kakar S; Aksoy S; Burgart LJ; Smyrk TC Mod Pathol; 2004 Jun; 17(6):696-700. PubMed ID: 15017435 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Sinicrope FA; Rego RL; Halling KC; Foster N; Sargent DJ; La Plant B; French AJ; Laurie JA; Goldberg RM; Thibodeau SN; Witzig TE Gastroenterology; 2006 Sep; 131(3):729-37. PubMed ID: 16952542 [TBL] [Abstract][Full Text] [Related]
15. Methylation of hMLH1 in a population-based series of endometrial carcinomas. Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752 [TBL] [Abstract][Full Text] [Related]
16. hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037 [TBL] [Abstract][Full Text] [Related]
17. Defective mismatch repair and the development of recurrent endometrial carcinoma. Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202 [TBL] [Abstract][Full Text] [Related]
18. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550 [TBL] [Abstract][Full Text] [Related]
19. Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: relationship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas. Chapusot C; Martin L; Mungra N; Rageot D; Bouvier AM; Bonithon Kopp C; Ponnelle T; Faivre J; Piard F Histopathology; 2003 Jul; 43(1):40-7. PubMed ID: 12823711 [TBL] [Abstract][Full Text] [Related]
20. BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers. Miturski R; Bogusiewicz M; Tarkowski R; Ciotta C; Bignami M; Burnouf D; Jakowicki JA Oncol Rep; 2003; 10(4):1039-43. PubMed ID: 12792767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]